BioSpace News Archive

Physicians in Novitas jurisdictions may now seek professional payment for insertion of DEXTENZA® using CPT code 0356T

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2020 earnings release and conference call.

Topline Results from GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil, Cardiac Myosin Activator, Expected in Q4 Licensing Collaboration and Royalty Monetization Deals with Xi Jing Pharmaceuticals and RTW Investments Accelerate and Expand Development of CK-3773274, Next Generation Cardiac Myosin Inhibitor Leveraging Partnerships to Finance Build of Commercial Business SOUTH SAN FRANCISCO, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) m

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that it has entered into an agreement with Sterling Pharma USA LLC for US production of WP1122 to support its expanded devel

AstraZeneca today announced that Survivors Have Heart, a national community-building movement powered by stories of heart attack survivors and their loved ones, will return for its third year.

ZYUS Life Sciences Inc. (“ZYUS”), a company dedicated to improving quality of life through research and leadership in bio-pharmaceuticals and cannabinoid-based formulations, announced today that it has reached a positive milestone in the development of COVID-19 vaccine components by achieving plant-based expression, isolation, and purification of a potential antigen for a SARS-CoV-2 vaccine - providing proof of concept for plant-based COVID-19 antigen production.

Sonnet BioTherapeutics, Inc., a company developing innovative targeted biologic drugs with enhanced single or bispecific mechanisms, announced today that Pankaj Mohan, PhD, Founder and Chief Executive Officer, John Cini, PhD, Co-founder and Chief Scientific Officer and Jay Cross, Chief Financial Officer, will be presenting a corporate overview at the BTIG Virtual Biotechnology Conference, held August 10-11, 2020.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ProFound AI™ Risk received a CE Mark in Europe

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the initiation of a multicenter prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health

AnHeart Therapeutics, Co., Ltd . (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, today announced that it has, through its subsidiary AnHeart Therapeutics Inc., outlicensed clinical development and commercialization rights to its next-generation ROS1/NTRK inhibitor, taletrectinib, to NewG Lab Co., Ltd. in the Republic of Korea (Korea) market. As part of the deal, AnHeart will